The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
The Center for Metabolic Origins of Disease studies common diseases that have reached pandemic scale including obesity, type 2 diabetes and cardiovascular complications. We have established an exciting environment that promotes multi-disciplinary discovery research toward breakthrough preventive and therapeutic strategies.
Infectious diseases such as HIV/AIDS and tuberculosis continue to rank high among global mortality factors, especially in developing countries, and systemic inflammation has been identified as a root case of many chronic disorders in the developed world.
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast. By 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Diseases that predominantly affect children are too often unaddressed by the biopharmaceutical industry and government funding agencies. Rare childhood diseases – those affecting fewer than 200,000 in the U.S – are especially overlooked.